
NASA said Thursday that it will bring four astronauts aboard the International Space Station back to Earth more than a month earlier than planned.
The space agency said Wednesday that it was postponing Thursday’s planned spacewalk because of a medical issue with one of the astronauts.
Citing medical privacy concerns, NASA did not provide additional details, including the identity of the affected crew member, the nature of the medical issue or its severity.
“After discussions with chief health and medical officer Dr. JD Polk and leadership across the agency, I’ve come to the decision that it’s in the best interest of our astronauts to return Crew-11 ahead of their planned departure,” NASA Administrator Jared Isaacman said at a news briefing.
In an update early Thursday, NASA had said that the situation was stable but that officials were weighing whether to bring several of the astronauts back to Earth earlier than planned — a rare move.
“Safely conducting our missions is our highest priority, and we are actively evaluating all options, including the possibility of an earlier end to Crew-11’s mission,” NASA officials wrote in a blog post.
The Crew-11 mission launched to the space station on Aug. 1, carrying NASA astronauts Zena Cardman and Mike Fincke, Japanese astronaut Kimiya Yui and Russian cosmonaut Oleg Platonov aboard a SpaceX Crew Dragon capsule. The four were expected to remain aboard the orbiting laboratory until late February.
This article was originally published on NBCNews.com
LATEST POSTS
- 1
SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos) - 2
The most exciting exoplanet discoveries of 2025 - 3
IDF: Staying in West Bank refugee camps will quell lone-wolf terror - 4
White House responds to Sabrina Carpenter after pop star slams 'evil' ICE video using her song - 5
Former GLP-1 users regain lost weight after about 18 months, study says
Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment
Why doing good also makes us feel good, during the holidays and beyond
Historical mysteries solved by science in 2025
Get To Be familiar with The Historical backdrop Of Western Medication
The most effective method to Explore Moral Situations in Brain research with Your Certification
US FDA approves Kura-Kyowa's blood cancer therapy
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers












